Objectives. To describe collection and reporting of gender data, including for transgender individuals and other gender minorities, in HIV and sexually transmitted infection (STI) surveillance in the United States.
T he term "gender minorities" refers to individuals who are transgender-whose gender does not align with sex at birth-or gender nonconforming-whose gender is incongruent with "man" or "woman." Gender minorities face substantial health disparities, including higher prevalence of HIV and sexually transmitted infections (STIs). 1, 2 The federal government's Healthy People 2020 program, the National Academy of Medicine (formerly the Institute of Medicine), and others have recommended improved collection of genderrelated data in clinical, research, and public health settings to help mitigate these disparities.
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We assessed collection and reporting of gender in HIV and STI surveillance in the United States.
METHODS
We conducted a cross-sectional study of US jurisdictions that, according to the Centers for Disease Control and Prevention (CDC), were among the top 50 jurisdictions for incident HIV, gonorrhea, chlamydia, or primary and secondary syphilis infections in 2015.
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RESULTS
We analyzed HIV and sexually transmitted infection CMR forms and HIV and STI surveillance reports for 71 jurisdictions meeting inclusion criteria. We excluded 1 jurisdiction's sexually transmitted infection CMR form that was solely electronic and available only to reporting clinicians and laboratories. The k statistic for interrater reliability was 0.998 (95% confidence interval = 0.993, 1.000).
Among HIV CMR forms, 60 of 71 (85%) included specific options (transgender, maleto-female, female-to-male, nonbinary, or intersex) for reporting gender minorities for the infected person, and 7 of 71 (10%) included those options for sex partners. Among sexually transmitted infection CMR forms, 33 of 70 (47%) included those options for the infected person and 17 of 70 (24%) for sex partner (Table 1) .
Specific gender minority categories for infected persons were included in 22 of 71 (31%) of HIV surveillance reports and 8 of 71 (11%) of STI surveillance reports (Table 1) . No jurisdictions reported gender minority sex partners.
DISCUSSION
Collection and reporting of gender minorities in HIV and STI surveillance were suboptimal and inconsistent, particularly for STIs. Gender minority data were collected more often than they were reported, suggesting barriers to reporting. State-and national-level disease surveillance relies on data collection by local jurisdictions, which typically have some discretion over the methods used to gather information. Although some jurisdictions replicated CMR form templates designed by state health departments or the CDC, other jurisdictions generated their own CMR forms, leading to considerable heterogeneity in collection of gender data (Table 1) . That variability in collection of gender data on CMR forms by local health departments might hinder meaningful data compilation and reporting at the state and national levels. For example, transgender women in Texas could be reported as "transgender" in 1 county but could be reported as "transgender female" Note. CMR = confidential morbidity report; FTM = female-to-male; MTF = male-to-female; STI = sexually transmitted infection.
in another county. The less specific term, "transgender," might be used at the state level to aggregate data, losing meaningful information on epidemiologically distinct populations. Still other collection forms used only nonspecific nonbinary terms such as "unknown" or "other," which cannot be meaningfully interpreted. This might lead to exclusion of gender minorities on surveillance reports stemming from inability to aggregate inconsistent gender data variables. These deficiencies run counter to recommendations from Healthy People 2020 and other organizations for robust data collection among gender minorities. This study is subject to at least 2 limitations. First, jurisdictions might collect information about the gender of infected persons and partners outside the CMR (e.g., through investigations by public health workers). Second, our use of state-level surveillance reports might have missed gender minority data disseminated locally but unavailable to our search methods.
PUBLIC HEALTH IMPLICATIONS
To improve gender-related HIV and STI surveillance, the CDC and state and local health departments should establish standards for the collection and reporting of gender in HIV and STI surveillance. Several challenges to implementing this recommendation exist. First, validated methods for gender data collection in disease surveillance are lacking, although they are currently under development for use in clinical and population health settings. [9] [10] [11] In the absence of validated methods, data collection and reporting should be consistent with minimum requirements for electronic health records established by the Centers for Medicare and Medicaid services. 12 On the basis of these requirements, data collection options should at a minimum include "male," "female," "transgender male (female-to-male, FTM)," "transgender female (male-to-female, MTF)," "genderqueer/neither exclusively male or female," and "additional gender category or other." An alternative 2-question method to identify gender minoritiesrequesting assigned sex at birth and current gender identity separately-has been endorsed and validated outside disease surveillance and should also inform standardization efforts. [9] [10] [11] Second, in some states, laboratories may share reporting responsibilities with providers. In this instance, laboratories rely on clinicians and, increasingly, electronic health records to enter accurate gender information on requisition forms. Health systems should aim to document gender correctly in the electronic record at the patient's initial point of contact with the system to ensure that gender data are accurately populated onto requisitions. Public health surveillance officers can also help to fill in missing information regarding gender identity of the infected persons and their partners where resources allow.
The collection of standardized gender data using validated methods would be a step in the right direction toward understanding the true burden of HIV and STIs among gender minorities. Once standards for surveillance have been developed, local public health departments should adopt those standards in updating HIV and sexually transmitted infection CMR forms and publishing surveillance reports. Robust gender-related data from disease surveillance could help health officials and other stakeholders better develop, monitor, and evaluate HIV and STI prevention and control efforts among transgender and other gender minority persons.
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